Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Mellid
Institution:
Spanish National Cancer Research Centre
Observed institutions:
Universitat Autònoma de Barcelona,
Consejo Superior de Investigaciones Científicas,
Spanish National Cancer Research Centre,
Centro Nacional de Biotecnología,
Vall d'Hebron Hospital Universitari
ORCID:
0000-0003-3637-3039
Observed ORCID:
0000-0003-3637-3039
OpenAlex ID:
A5043517249
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
2023
·
Bruna Calsina
, Elena Piñeiro-Yáñez
, et al.
·
Nature Communications
·
121
PDF
Genetic bases of pheochromocytoma and paraganglioma
2022
·
Alberto Cascón
, Bruna Calsina
, et al.
·
Journal of Molecular Endocrinology
·
74
PDF
Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas
2021
·
Yadileiny Portilla
, Sara Mellid
, et al.
·
ACS Applied Materials & Interfaces
·
59
Defective function of α-ketoglutarate dehydrogenase exacerbates mitochondrial ATP deficits during complex I deficiency
2023
·
Gerardo G. Piroli
, Allison M. Manuel
, et al.
·
Redox Biology
·
25
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
2021
·
María Monteagudo
, Paula Martínez
, et al.
·
Cancers
·
24
PDF
Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome
2020
·
Maria I. Vanegas
, Anna Marcé-Grau
, et al.
·
Parkinsonism & Related Disorders
·
23
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
2020
·
Sara Mellid
, Javier Coloma
, et al.
·
Cancers
·
17
PDF
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
2024
·
María Monteagudo
, Bruna Calsina
, et al.
·
Best Practice & Research Clinical Endocrinology & Metabolism
·
16
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
2023
·
Sara Mellid
, Eduardo Gil
, et al.
·
Frontiers in Endocrinology
·
16
PDF
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition
2023
·
Juan M. Roldán‐Romero
, Carlos Valdivia
, et al.
·
International Journal of Cancer
·
15
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
2023
·
Sara Mellid
, Fernando García
, et al.
·
癌症:英文版
·
9
Identification of a novel papillary renal cell carcinoma molecular subtype characterized by HIF-pathway over-activation
2025
·
Javier de Nicolás-Hernández
, Alicia Arenas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomas
2025
·
Sara Mellid
, Eduardo Caleiras
, et al.
·
Genes & Diseases
·
1
Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer
2025
·
Natalia Martínez-Puente
, Ignacio Ruz-Caracuel
, et al.
·
Laboratory Investigation
PDF
Expression of HSA-MIR-139-5P as a clinically feasible prognostic marker for thyroid cancer
2024
·
Natalia Martinez-Puente
, Ignacio Ruz-Caracuel
, et al.
·
Endocrine Abstracts
Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 Dysregulation
2021
·
Juan M. Roldán-Romero
, Maria Santos
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
16
Citation count:
402
H-index:
10
I10-index:
10
Year
Topic
Type